A select combination of clinically relevant phytoestrogens enhances estrogen receptor β-binding Selectivity and neuroprotective activities in vitro and in vivo

Endocrinology

Volumn 150, Issue 2, 2009, Pages 770-783

  Zhao, Liqin ^a   Mao, Zisu ^a   Brinton, Roberta Diaz ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DAIDZEIN; EQUOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; IBSO 03569; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FEMALE; HORMONE BINDING; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; UTERUS CAVITY;

ANIMALS; BRAIN; CELLS, CULTURED; CYTOPROTECTION; DRUG COMBINATIONS; ENERGY METABOLISM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MODELS, BIOLOGICAL; NEURONS; NEUROPROTECTIVE AGENTS; OVARIECTOMY; PHYTOESTROGENS; PREGNANCY; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY; UP-REGULATION;

EID: 59649094237     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0715     Document Type: Article

References (61)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288:321-333
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, CaanB, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, VanHorn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291: 1701-1712
3. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
4. Shumaker SA, Legault C, Kuller LH, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH 2004 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958
5. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J 2004 Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2959-2968
6. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-2672
7. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML 2007 Estrogen therapy and coronary-artery calcification. N Engl J Med 356:2591-2602
8. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML 2007 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465-1477
9. Brinton RD 2005 Estrogen therapy for prevention of Alzheimer's disease but not for rehabilitation following onset of disease: the healthy cell bias of estrogen action. In: Baudry M, Bi X, Schreiber SS, eds. Synaptic plasticity: basic mechanisms to clinical applications. Boca Raton, FL: Taylor & Francis Group; 131-157
10. Brinton RD 2005 Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci 1052:57-74
11. MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP, Taylor AW 2006 Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13:28 -36
12. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC 2002 Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288: 2123-2129
13. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA 2007 The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674
14. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ 2003 Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289:2673-2684
15. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J 2006 Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113: 2425-2434
16. Zhao L, Brinton RD In search of estrogen alternatives for the brain. In: Hogervorst E, ed. Hormones,cognition and dementia: state of the art and emergent therapeutic strategies. Oxford, UK: Oxford University Press, in press
17. Zhao L, Brinton RD 2007 WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev Neurother 7:1549 -1564
18. Maskarinec S 2003 The effect of phytoestrogens on hot flashes. Nutrition Bytes 9(2):article 5
19. Ziegler RG 2004 Phytoestrogens and breast cancer. Am J Clin Nutr 79: 183-184
20. Henderson BE, Bernstein L 1991 The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 18(Suppl 1): S11-S17
21. Goetzl MA, Van Veldhuizen PJ, Thrasher JB 2007 Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis 10:216-223
22. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, Jacques PF 2001 Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr 131: 1826 -1832
23. Rice MM, LaCroix AZ, Lampe JW, van Belle G, Kestin M, Sumitani M, Graves AB, Larson EB 2001 Dietary soy isoflavone in take in older Japanese American women. Public Health Nutr 4:943-952
24. Zhao L, Chen Q, Brinton RD 2002 Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med 227:509-519
25. Zhao L, Brinton RD 2007 Estrogen receptor α and β differentially regulate intracellular Ca(2 +) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 1172:48 -59
26. Zhao L, Wu TW, Brinton RD 2004 Estrogen receptor subtypes α and β contribute to neuroprotection and increased Bcl-2 expression in primary hip- pocampal neurons. Brain Res 1010:22-34
27. Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA 2002 Disruption of estrogen receptor β gene impairs spatial learning in female mice. Proc Natl Acad Sci USA 99:3996-4001
28. Day M, Sung A, Logue S, Bowlby M, Arias R 2005 β Estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioning. Behav Brain Res 164:128 -131
29. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, Grauer S, Zhang G, Kelley C, Pulito V, Sung A, Mervis RF, Navarra R, Hirst WD, Reinhart PH, Marquis KL, Moss SJ, Pangalos MN, Brandon NJ 2008 Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11:334-343
30. Mersereau JE, Levy N, Staub RE, Baggett S, Zogric T, Chow S, Ricke WA, Tagliaferri M, Cohen I, Bjeldanes LF, Leitman DC 2008 Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist. Mol Cell Endocrinol 283:49-57
31. Lund TD, Rovis T, Chung WC, Handa RJ 2005 Novel actions of estrogen receptor-β on anxiety-related behaviors. Endocrinology 146:797-807
32. Walf AA, Frye CA 2007 Administration of estrogen receptor β-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86: 407-414
33. Zhao L, Brinton RD 2006 Estrogen receptor β as a therapeutic target for promotion of neurogenesis and prevention of neurodegeneration. Drug Dev Res 66:103-117
34. Zhao L, JinC, Mao Z, GopinathanMB, Rehder K, BrintonRD 2007 Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator-a hybrid structure of 17β-estradiol and vitamin E in hippocampal neurons. J Med Chem 50:4471-4481
35. Zhao L, O'Neill K, Brinton RD 2006 Estrogenic agonist activity of ICI 182, 780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther 319:1124-1132
36. Nilsen J, Irwin RW, Gallaher TK, Brinton RD 2007 Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci 27:14069-14077
37. Zhao L, Brinton RD 2005 Structure-based virtual screening for plant-based ERβ-selective ligands as potential preventative therapy against age-related neurodegenerative diseases. J Med Chem 48:3463-3466
38. Zhao L, BrintonRD 2006 Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci 7:24
39. Nilsen J, Brinton RD 2004 Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 3:297-313
40. Wallace DC 2005 A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407
41. Moreira PI, Cardoso SM, Santos MS, Oliveira CR 2006 The key role of mitochondria in Alzheimer's disease. J Alzheimers Dis 9:101-110
42. Lin MT, Beal MF 2006 Alzheimer's APP mangles mitochondria. Nat Med 12:1241-1243
43. Pike CJ 1999 Estrogen modulates neuronal Bcl-xL expression and β-amy- loid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72: 1552-1563
44. Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD 2006 Estrogen protects neuronal cells from amyloid β-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci 7:74
45. Nilsen J, Brinton RD 2003 Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA 100:2842-2847
46. Wu TW, Wang JM, Chen S, Brinton RD 2005 17β-Estradiol induced Ca2 + influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135:59-72
47. Eckman EA, Eckman CB 2005 Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33:1101-1105
48. Higuchi M, Iwata N, Saido TC 2005 Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions. Biochim Biophys Acta 1751:60-67
49. Weiser MJ, Foradori CD, Handa RJ 2007 Estrogen receptor β in the brain: from form to function. Brain Res Rev 57:309-320
50. Lee YB, Lee HJ, Sohn HS 2005 Soy isoflavones and cognitive function. J Nutr Biochem 16:641-649
51. Patisaul HB 2005 Phytoestrogen action in the adult and developing brain. J Neuroendocrinol 17:57-64
52. Setchell KD, Brown NM, Desai P, Zimmer-NechemiasL, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE 2001 Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131(Suppl):1362S-1375S
53. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M 1984 Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40:569-578
54. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y 2001 Interaction of phytoestrogens with estrogen receptors α and β. Biol Pharm Bull 24:351-356
55. Setchell KD, Brown NM, Lydeking-Olsen E 2002 The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584
56. Atkinson C, Frankenfeld CL, Lampe JW 2005 Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 230:155-170
57. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ 2004 Comparisons of percent equol producers between prostate cancer patients and controls: case controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86-89
58. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S 2000 Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10:127-135
59. Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, Holt VL, Schwartz SM, Lampe JW 2006 Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas 53:315-324
60. Niculescu MD, Pop EA, Fischer LM, Zeisel SH 2007 Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem 18:380-390
61. Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, Ishimi Y 2007 Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 14:866 -874